Sai Life Sciences Faces Order Regarding CGST Act

Sai Life Sciences received an order on November 12, 2025, from the Assistant Commissioner, Central Tax, Division-II (Pimpri), Pune-I Commissionerate, regarding Section 74 of the CGST Act, 2017. The order demands INR 70,15,687 in IGST, along with applicable interest and a penalty of the same amount. The company plans to file an application for rectification and anticipates a favorable outcome.

Details of the Order

The company received an order from the Assistant Commissioner, Central Tax, Division-II (Pimpri), Pune-I Commissionerate, concerning the Goods and Services Tax Act. The order, issued on November 12, 2025, demands payment related to IGST.

Financial Implications

The order specifies a demand of INR 70,15,687 related to IGST. Additionally, the order includes applicable interest charges and a penalty of INR 70,15,687.

Alleged Violation

The demand relates to alleged excess availment of Input Tax Credit (ITC) and a difference between B2B supply and the Sale/Purchase register updated on the government portal. This pertains to financial years 2018-19 to 2021-22.

Company’s Response

Sai Life Sciences plans to file an application for rectification of the order. The company is optimistic about a favorable resolution and currently anticipates that the order will not have a material financial impact.

Source: BSE

InvestyWise News
InvestyWise News
Covers market-moving news with speed and precision, delivering sharp insights to help readers stay ahead in the fast-paced world of stocks.

Latest articles

Related articles

Leave a reply

Please enter your comment!
Please enter your name here
Captcha verification failed!
CAPTCHA user score failed. Please contact us!